Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Doxazosin[1] Doxazosin (Doxazosinum)[2] Doxazosin mesylate (Doxazosin mesylate, Doxazosin mesilate, DOXAZOSIN),
Doxazosin (Doxazosin) 💬 		[3] ADRA1A,
ADRA1B,
ADRA1D 💬 		[9] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 57, 67 💬
2Metoprolol succinate + doxazosin[2] Doxazosin (Doxazosinum),
Metoprolol		[6] Metoprolol tartrate ,
Doxazosin mesylate (Doxazosin mesylate, Doxazosin mesilate, DOXAZOSIN),
Metoprolol succinate ,
Metoprolol ,
Metoprolol fumarate ,
Doxazosin (Doxazosin) 💬 		[4] ADRA1A,
ADRA1B,
ADRA1D,
ADRB1 💬 		[15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 57 💬